1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010; 37: 13-25.
2.
Abdullahi W, Tripathi D, Ronaldson PT. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol 2018; 315: C343-C356.
3.
Atucha E, Hammerschmidt F, Zolle I, Sieghart W, Berger ML. Structure-activity relationship of etomidate derivatives at the GABA(A) receptor: Comparison with binding to 11beta-hydroxylase. Bioorg Med Chem Lett 2009; 19: 4284-4287.
4.
Beard RS, Jr., Reynolds JJ, Bearden SE. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood 2011; 118: 2007-2014.
5.
Berndt P, Winkler L, Cording J, Breitkreuz-Korff O, Rex A, Dith-mer S, Rausch V, Blasig R, Richter M, Sporbert A, Wolburg H, Blasig IE, Haseloff RF. Tight junction proteins at the blood–brain barrier: far more than claudin-5. Cell Mol Life Sci 2019; 76: 1987-2002.
6.
Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, Donnan GA. Ischaemic stroke. Nat Rev Dis Primers 2019; 5: 70.
7.
Cao Y, Su N, Zhang D, Zhou L, Yao M, Zhang S, Cui L, Zhu Y, Ni J. Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study. Eur J Neurol 2021; 28: 1931-1938.
8.
Caprio FZ, Sorond FA. Cerebrovascular disease: primary and secondary stroke prevention. Med Clin North Am 2019; 103: 295-308.
9.
Chiara DC, Jounaidi Y, Zhou X, Savechenkov PY, Bruzik KS, Miller KW, Cohen JB. General anesthetic binding sites in human alpha4beta3delta gamma-aminobutyric acid type A receptors (GABAARs). J Biol Chem 2016; 291: 26529-26539.
10.
Chiplunkar AR, Curtis BC, Eades GL, Kane MS, Fox SJ, Haar JL, Lloyd JA. The Kruppel-like factor 2 and Kruppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis. BMC Dev Biol 2013; 13: 40.
11.
Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol 2015; 7: a020412.
12.
Dayal S, Lentz SR. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 2008; 28: 1596-1605.
13.
De Bree A, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002; 54: 599-618.
14.
Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011; 114: 695-707.
15.
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J 2015; 14: 6.
16.
Grandi V, Bacci S, Corsi A, Sessa M, Puliti E, Murciano N, Scavone F, Cappugi P, Pimpinelli N. ALA-PDT exerts beneficial effects on chronic venous ulcers by inducing changes in inflammatory microenvironment, especially through increased TGF-beta release: A pilot clinical and translational study. Photodiagnosis Photodyn Ther 2018; 21: 252-256.
17.
Han J, Chen X. A meta-analysis of cigarette smoking prevalence among adolescents in China: 1981-2010. Int J Environ Res Public Health 2015; 12: 4617-4630.
18.
Han L, Jiang C. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B 2021; 11: 2306-2325.
19.
Janus A, Dumas D, Le Douce J, Marie S, Pasculli G, Bambury P, Lemarchant S, Kremer P, Godfrin Y. Pharmacokinetic-pharmacodynamic relationship of NX210c peptide in healthy elderly volunteers: randomized, placebo-controlled, double-blind, multiple ascending dose study. Front Neurosci 2025; 14: 357-377.
20.
Jeffrey JL, Ronaldson PT, Davis TP. The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: Antioxidants in clinical trials. Biochem Pharmacol 2024; 228: 116186.
21.
Jiang X, Andjelkovic AV, Zhu L, Yang T, Bennett MVL, Chen J, Keep RF, Shi Y. Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 2018; 163-164: 144-171.
22.
Katan M, Luft A. Global burden of stroke. Semin Neurol 2018; 38: 208-211.
23.
Keaney J, Campbell M. The dynamic blood-brain barrier. FEBS J 2015; 282: 4067-4079.
24.
Kumar M, Sandhir R. Hydrogen sulfide attenuates hyperhomocysteinemia-induced blood-brain barrier permeability by inhibiting MMP-9. Int J Neurosci 2022; 132: 1061-1071.
25.
Lehotsky J, Tothova B, Kovalska M, Dobrota D, Beňová A, Kalenská D, Kaplán P. Role of homocysteine in the ischemic stroke and development of ischemic tolerance. Front Neurosci 2016; 10: 538.
26.
Li D, Lv J, Liu F, Liu P, Yang X, Feng Y, Chen G, Hao M. Hypertension burden and control in mainland China: Analysis of nationwide data 2003-2012. Int J Cardiol 2015; 184: 637-644.
27.
Li T, Yang L, Tu J, Hao Y, Zhu Z, Xiong Y, Gao Q, Zhou L, Xie G, Zhang D, Li X, Jin Y, Zhang Y, Zhao B, Xi N, Jia W. The myeloid cell-driven transdifferentiation of endothelial cells into pericytes promotes the restoration of BBB function and brain self-repair after stroke. Elife 2025; 16: RP105593.
28.
Li W, Yuan W, Zhang D, Cai S, Luo J, Zeng K. LCZ696 possesses a protective effect against homocysteine (Hcy)-induced impairment of blood-brain barrier (BBB) integrity by increasing occludin, mediated by the inhibition of Egr-1. Neurotox Res 2021; 39: 1981-1990.
29.
Liao Y, Liu X, Jounaidi Y, Forman SA, Feng HJ. Etomidate effects on desensitization and deactivation of a4b3d GABAA receptors inducibly expressed in HEK293 TetR cells. J Pharmacol Exp Ther 2019; 368: 100-105.
30.
Lin Z, Natesan V, Shi H, Dong F, Kawanami D, Mahabeleshwar GH, Atkins GB, Nayak L, Cui Y, Finigan JH, Jain MK. Kruppel-like factor 2 regulates endothelial barrier function. Arterioscler Thromb Vasc Biol 2010; 30: 1952-1959.
31.
Liu M, Zhang Y, Xiong JY, Wang Y, Lv S. Etomidate mitigates lipopolysaccharide-induced CD14 and TREM-1 expression, NF-kappaB activation, and pro-inflammatory cytokine production in rat macrophages. Inflammation 2016; 39: 327-335.
32.
Ma S, Lu G, Zhang Q, Ding N, Jie Y, Zhang H, Xu L, Xie L, Yang X, Zhang H, Jiang Y. Extracellular-superoxide dismutase DNA methylation promotes oxidative stress in homocysteine-induced atherosclerosis. Acta Biochim Biophys Sin (Shanghai) 2022; 54: 1222-1233.
33.
McCully KS. Homocysteine and the pathogenesis of atherosclerosis. Expert Rev Clin Pharmacol 2015; 8: 211-219.
34.
Okada T, Suzuki H, Travis ZD, Zhang JH. The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target. Curr Neuropharmacol 2020; 18: 1187-1212.
35.
Otani T, Furuse M. Tight junction structure and function revisited. Trends Cell Biol 2020; 30: 805-817.
36.
Pejo E, Santer P, Wang L, Dershwitz P, Husain SS, Raines DE. Gamma-aminobutyric acid type A receptor modulation by etomidate analogs. Anesthesiology 2016; 124: 651-663.
37.
Poddar R, Paul S, Paul S. Homocysteine-induced endoplasmic reticulum stress causes differential expression of activating transcription factors and apoptosis in neuronal cells. Neurochem Int 2017; 110: 57-67.
38.
Rom S, Dykstra H, Zuluaga-Ramirez V, Reichenbach NL, Persidsky Y. miR-98 and let-7g* protect the blood-brain barrier under neuroinflammatory conditions. J Cereb Blood Flow Metab 2015; 35: 1957-1965.
39.
Rosenberg GA. Ischemic brain edema. Prog Cardiovasc Dis 1999; 42: 209-216.
40.
Shen S, Wang J, Zhao Q, Hu Q. The protective effects of butorphanol tartrate against homocysteine-induced blood-brain barrier dysfunction. Bioengineered 2022; 13: 7209-7220.
41.
Stokum JA, Gerzanich V, Simard JM. Molecular pathophysiology of cerebral edema. J Cereb Blood Flow Metab 2016; 36: 513-538.
42.
Sweet DR, Vasudevan NT, Fan L, Booth CE, Keerthy KS, Liao X, Vinayachandran V, Takami Y, Tugal D, Sharma N, Chan ER, Zhang L, Qing Y, Gerson SL, Fu C, Wynshaw-Boris A, Sangwung P, Nayak L, Holvoet P, Matoba K, Lu Y, Zhou G, Jain MK. Myeloid Kruppel-like factor 2 is a critical regulator of metabolic inflammation. Nat Commun 2020; 11: 5872.
43.
Valk BI, Struys M. Etomidate and its analogs: A review of pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2021; 60: 1253-1269.
44.
Vuong CN, Mullenix GJ, Kidd MT, Bottje WG, Hargis BM, Tellez-Isaias G. Modified serum fluorescein isothiocyanate dextran (FITC-d) assay procedure to determine intestinal permeability in poultry fed diets high in natural or synthetic pigments. Poult Sci 2021; 100: 101138.
45.
Xie D, Li M, Yu K, Lu H, Chen Y. Etomidate alleviates cardiac dysfunction, fibrosis and oxidative stress in rats with myocardial ischemic reperfusion injury. Ann Transl Med 2020; 8: 1181.
46.
Yang C, Hawkins KE, Dore S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 2019; 316: C135-C153.
47.
Yang J, Uchida I. Mechanisms of etomidate potentiation of GABAA receptor-gated currents in cultured postnatal hippocampal neurons. Neuroscience 1996; 73: 69-78.
48.
Zhang YX, Wang ZX, Zhao JS, Chu ZH. Trends in overweight and obesity among rural children and adolescents from 1985 to 2014 in Shandong, China. Eur J Prev Cardiol 2016; 23: 1314-1320.
49.
Zhang ZX, Lu H, Dong XP, Liu J, Xu TL. Kinetics of etomidate actions on GABA(A) receptors in the rat spinal dorsal horn neurons. Brain Res 2002; 953: 93-100.
50.
Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201.